Tristel Share Price (TSTL)
| Bid price | 510.00 | Open price | 515.00 |
|---|---|---|---|
| Ask price | 530.00 | Prev close | 520.00 |
| High price | 0.00 | Spread | 3.77% |
| Low price | 0.00 | Volume | 0 |
Register now for FREE live Tristel share prices, Tristel stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Tristel Level 2 Data, indepth research tools and investor commentary for Tristel (TSTL) and other London Stock Exchange equities.
Tristel Share Price Chart
Register now for FREE Tristel share price charts
Tristel Share Price Information
| Name | Tristel | Epic | TSTL |
|---|---|---|---|
| Sector | n/a | ISIN | GB00B07RVT99 |
| Activites | n/a | Index | n/a |
Tristel Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 02/04/2025 | BUY | Elizabeth Dixon | RES | 5,000 |
| 26/03/2025 | BUY | Matthew Sassone | CEO | 3,500 |
| 20/09/2024 | SELL | Elizabeth Dixon | RES | 50,000 |
| 11/06/2024 | SELL | Paul Swinney | RES | 41,606 |
| 11/06/2024 | SELL | Paul Swinney | RES | 16,243 |
Tristel Company News
Update to Executive Performance Share Plan 2021
RNS Number : 2801H Tristel PLC 02 December 2020 Tristel plc ("Tristel" or the "Company") Update to Executive Performance Share Plan 2021 Tristel plc (AIM: TSTL), the manufacturer of infection prevention products,...
Tristel wins AIM Growth Business of the Year Award
RNS Number : 2772H Tristel PLC 02 December 2020 Tristel plc ("Tristel" or the "Company") Tristel wins AIM Growth Business of the Year Award Tristel plc (AIM: TSTL), the manufacturer of infection prevention products,...
Exercise of Options
RNS Number : 6595E Tristel PLC 09 November 2020 Tristel plc ("Tristel" or the "Company") Issue of Equity Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces...
Register now for FREE Tristel company news
Tristel Share Price Discussions
Healthcare Business Specialising in Infection Control (TSTL)
At a time of out-of control MRSA and other Diarrhoea bugs that are swamping our hospitals, Tristel which sells its bacteria destroying products to over 60% of all NHS hospitals, could be a little gem to add to your portfolio. Already a profitable company and with several patents and new products...
Register now for FREE Tristel share price discussions